This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|June 2, 2021
- Pharmaceutical Technology, June 2021 Issue
- Volume 45
- Issue 6
Double Planetary Mixer from ROSS
The ROSS Double Planetary Mixer from Charles Ross & Son Company is available with an optional weighing system for precise measurements throughout the batching procedure.
The ROSS Double Planetary Mixer from Charles Ross & Son Company is available with an optional weighing system for precise measurements throughout the batching procedure. The turnkey system (pictured) comes equipped with a mixer, weighing scale, and discharge system on mobile benches, with the ability to attach to one another, and to transfer carts of the same height. V-groove tracks allow easy movement of the Double Planetary Mixer vessel to the weighing station, and on to the discharge press for direct filling of syringes, tubes, or other containers.
Articles in this issue
over 5 years ago
New Biotherapies Push Technological Innovation Forwardover 5 years ago
Assessing Risk and Production of Potent Substancesover 5 years ago
Moving Beyond Particle Size Controlover 5 years ago
Cleaning Continuous Manufacturing Equipmentover 5 years ago
Considering Robotics for Drug Compoundingover 5 years ago
Considerations for Cleaning Biopharmaceutical Process Equipmentover 5 years ago
Navigating International Pharmacovigilanceover 5 years ago
Prioritizing Cleaning Validationover 5 years ago
Developing a Method for Success through PartnershipsRelated to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5